Thomas Tennant
Family Medicine · Coppell, TXNPI 1487725610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $793 and has fallen 79.6% since, to $162 in 2022.
Across 93 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$212
- AstraZeneca$199
- Novo Nordisk$117
- Gilead$100
- AbbVie$99
- Takeda Pharmaceuticals U.S.A., Inc.$93
- plus $607 from 20 others
What the payments were for
- Food & beverage$1,421100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $212 |
| AstraZeneca | 13 | $199 |
| Novo Nordisk | 8 | $117 |
| Gilead | 6 | $100 |
| AbbVie(2 entities) | 7 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $93 |
| Pfizer | 6 | $93 |
| Amarin Pharma, Inc. | 6 | $87 |
| Boehringer Ingelheim | 3 | $52 |
| Merck | 4 | $50 |
| Neos Therapeutics, LP | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Genentech USA, Inc. | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Lilly USA, LLC | 2 | $23 |
| Bayer | 1 | $19 |
| Lupin Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
| Acclarent, Inc | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Bausch Health US, LLC | 1 | $12 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$122
How this compares
$1,427 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Coppell
- Victor BurgosCoppell$124K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.